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pathogenesis of sepsis, ranging from harmfut hy- 
perinflammation to profound immunodeficient im- 
munoparatysis. The fever of monocyte HLA-DR ex- 
pression and production of tumor necrosis factor- 
atpha ex vivo show the functionat status of mono- 
cytes as antigen presenting cetts. Infectious inflam- 
mation atso affects granutocyte CD64 expression. 
Other proinflammatory and antiinflammatory cy- 
tokines (tipopotysaccharide binding protein, IL-6, 
IL-10) are invotved in the pathogenesis of sepsis. 
The study aimed to determine importance and 
feasibitity of their evatuation in patients with SIRS, 
sepsis and septic shock. 
Materials & Methods: 67 patients meeting the 
criteria for diagnosis of systemic inflammatory re- 
sponse syndrome, sepsis and septic shock according 
to the Consensus conference, were examined. For 
determination of HLA-DR on monocytes and gran- 
utocyte CD64 expression flow cytometry was used. 
Resutts were expressed as MFI (mean fluorescence 
intensity) and QuantiBRITE (quantitation of anti- 
bodies bound per cett, kit fy Becton-Dickinson). 
Production of TNF-~ ex vivo after tipopotysac- 
charide stimutation was evatuated by Vottbtut- 
stimutation Kit (Mittenia). Determination of PCT, 
IL-6, IL-10 was evatuated by using chemituminis- 
cence method. 
Results: Expression of HLA-DR on monocytes and 
TNF-~ production corretated significantty with diag- 
nosis (Spearman's corretation coefficient r=-0.38, 
resp. -0.40, P <0.0001). We found significant dif- 
ferences of both parameters between subgroups 
of patients with SIRS and sepsis (P=0.0005), 
or SIRS and septic shock (P=0.006). The vat- 
ues of expression of HLA-DR corretated signif- 
icantty with vatues of TNF-~ in patients with 
SIRS and sepsis (P=0.0004, resp. P=0.0003). Last 
measured vatues of HLA-DR on monocytes and 
production of TNF-~ were significantty tower in 
non-survivors compared to survivors (P<0.001, 
resp. P<0.05). CD64 on granutocytes were sig- 
nificantty tower in patients with SIRS com- 
pared to patients with sepsis and septic shock 
(P < 0.0001, resp. P < 0.00001 ). The determination 
of CD64/45 and HLA-DR on monocytes using MFI 
corretated with QuantiBRITE method (rho=0.883, 
resp. 0.739, P < 0.00001, resp. P < 0.00001 ). Mono- 
cyte HLA-DR expression corretates with C-reactive 
protein (rho=-0.444, p=0.038). CD64 expres- 
sion on granutocytes corretates with medi- 
ators of systemic inflammation (procatcitonin 
PCT (rho=0.438, p=0.002), proinflammatory cy- 
tokines - interteukin-6 (rho=0.456, p=0.001), 
tipopotysaccharide binding protein (rho=0.446, 
p=0.002) and atso anti-inflammatory cytokines - 
IL-10 (rho=0.422, p=0.003). 
Conclusion: The assessment of the intensity of 
the inflammatory response hetps to predict the 
outcome of patients with sepsis and septic shock. 
Quantitative monocyte HLA-DR expression, produc- 
tion of TNF-~ ex vivo and CD64 expression on gran- 
utocytes are usefut parameters in septic patients, 
especiatty together with the pane[ of inflammatory 
cytokines in tong-term monitoring and in the con- 
text of the ctinicat status. 
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Background: In the intensive care unit, thrombocy- 
topenia occurs in up to 20% of medica[ and 35% of 
surgica[ admissions. White there are many cause 
of thrombocytopenia in this setting, sepsis is a 
dear risk factor, with an estimated incidence of 
35-59%. In addition, there is an inverse retation- 
ship between the severity of sepsis and the ptate- 
[et count. Immune mechanisms may contribute 
to sepsis-induced thrombocytopenia. Nonspecific 
ptatetet-associated antibodies can be detected in 
up to 30% of ICU patients. Thrombocytopenia is 
a predictor of mortatity in ICU patients and in 
patients with severe sepsis. 
Objective: The aim of the study was to investigate 
immunotogica[ cause of thrombocytopenia in crit- 
icatty it[ patients and in the case of unsuccessfu[ 
standard therapy to use intravenous immunogtobu- 
tins. 
Subjects and Methods: 22 patients from ICU 
were investigated (8 women, 14 men) meeting the 
criteria of the Consensus conference about sep- 
sis. Art patients devetoped thrombocytopenia (tess 
than 50 G/L). 3 patients devetoped thrombocytope- 
nia tess than 5 G/L. These patients had petechie, 
bruising, and frank breeding. Ftow cytometry was 
used to detect ptatetet associated autoantibodies 
(fy Sitenius). 
Results: Of the 22 patients, positive ptatetet- 
associated immunogtobutins were detected in 7 pa- 
tients (32%). In 5 patients were ptatetet associated 
immunogtobutins positive in IgG and IgM isotype, 
in 2 patients in IgG, IgA, and IgM isotypes. 3 pa- 
tients had thrombocytopenia tess than 7G/L and 
did not answer to use of ptatetets concentrate, 
and were corticoresistant. For these patients we 
used the treatment with intravenous immunogtob- 
utins in immunosuppressive dose 400mg/kg/day. 
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In the cumutative dose 60g of IVIG the number 
of ptatetets increased to 30G/L and the breeding 
disappeared. We decided to finish the treatment 
increasing number of ptatetets to 50 G/L. 
Conclusion: The use of intravenous immunogtob- 
utins in immunosuppressive doses is indicated in 
patients with thrombocytopenia associated with 
ptatetet associated autoantibodies and resistant 
to conventionat reatment. Severat mechanisms of 
action have been suggested for the therapeutic 
action of IVIG. 
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Background: Currentty, the cotocation of a centrat 
venous catheter (CVC), is an essentiat procedure 
in the medicat care and it impties a significant 
risk of morbidity and mortatity for art the patients. 
Primary nosocomiat bacteremia (PNB) is the princi- 
pat infectious comptication, it increase the days of 
hospitatization, costs and put in risk the rife of the 
patient. 
Objective: To determine the frequency of Noso- 
comiat Bacteremia retated to the use of CVC in 
patients of the Intensive Care Unit, Surgery and 
Medicine wards. 
Methods: From March to September 2005 a descrip- 
tive and prospective study was made in patients 
who carried CVC, hospitatized in ICU and wards of 
surgery and medicine in the "Rufz y P&ez" Univer- 
sity Hospitat of Botivar City, Venezueta. 37 patients 
were studied using the Macki's technique for the 
microbiotogicat diagnosis. 
Results: The frequency of PNB retated to CVC 
was 35.13% (13/37) (X2=3.97, P>0.05). It was 
more frequent in ICU patients 61.53% (8/13) 
(X 2 = 25.77, P < 0.001 ), in medicine services 35.45% 
(5/13), there was not any case reported in surgery 
wards. The Gram-positive cocci were the princi- 
pat etiotogica[ agents 62.41% (10/16). The iden- 
tified microorganisms were Staphylococcus au- 
reus in 3/16, Staphylococcus haemolyticus 3/16, 
Pseudomonas aerusinosa 3/16, Staphylococcus epi- 
dermidis 2/16, and Staphylococcus warneri 2/16 
(X2=4.00; P>0.05). The identified factors of risk 
were: duration of CVC greater than 4 days, pres- 
ence of previous infection to the entrance site of 
catheter, difficutt insertion of the CVC, previous 
invasive procedures and severity of undertying dis- 
ease or associate. The protonged maintenance of 
the CVC was the more important factor 27.02% 
(10/37) (X 2 =4.25, P >0.05). The more frequentty 
observed comptications were: protonged hospitat- 
ization in 53.87% (7/13), increase of costs 53.87% 
(7/13) and increase of morbidity 23.07% (3/13) 
(X 2 = 8.18; P < 0.05). There was no mortatity in pa- 
tients with PNB retated to CVC. 
Conclusions: It was demonstrated that in ICU the 
frequency of PNB retated to CVC was greater than 
in the surgicat and medicat wards. The Macki's 
technique was used in this study, by being simpte 
in its apptication, tess expensive and retiabte. 
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Background: Experimentat evidence suggests that 
time of beta-tactam antibiotics brood revers above 
MIC is a key factor for treatment efficacy. Low 
revers may be associated with treatment faiture, 
white high revers may increase toxicity, especiatty 
in patients with impaired renat function. 
Objective: To report the experience with TDM in 
adutt patients receiving IMP or CEF therapy. 
Methods: Retrospective anatysis of consecutive IMP 
or CEF TDM during a 1-year period. Initiat drug dos- 
ing was based on standard recommendations. IMP 
or CEF trough brood revers (Cm~n) were measured 
by HPLC. Interpretation of Cm~n as appropriate (A), 
inappropriate tow (L) or inappropriate high (H) 
was based on MIC (when avaitabte), ctinicat and 
microbiotogicat response, renat function, and drug 
brood revers reported in ctinicat studies. For L or H 
drug revers, interventions were proposed. 
Results: 56 drug revers were measured (IMP, n = 30; 
CEF, n=26) in 29 hemato-oncotogy, 11 intensive 
care, and 16 other adutt patients. Treatment indi- 
cations were microbiotogicatty (27) or ctinicatty (7) 
documented infections or unexptained fever (21). 
Dairy dosing ranged from 500 to 4000 mg (IMP) and 
500 to 6000 mg (CEF). TDM was performed 4 days 
(median, range 1-25) after treatment initiation: 
Cm~n ranged from 0 to 13 (IMP) and 0.7 to 61 mg/L 
